Search
-
Future-proof your brand during inflationary times
Timely insights to help brands future-proof their growth during inflationary times.
-
A new era in multiple sclerosis
Momentum continues to build in the use of high-efficacy, disease modifying therapies (DMTs) as a first choice for treating multiple sclerosis. How is this being influenced by the availability of anti-CD20s, a new class of DMT? Will future new therapy classes change the paradigm even further?
-
Taking steps towards sustainable travel
Global Ipsos polling finds many people are open to becoming more sustainable tourists.
-
Continued growth in an uncertain environment
Ipsos’ business continues to grow well, despite the effects of the war in Ukraine and new lockdowns in China. The majority of our service lines are seeing double digit growth. We have been able to respond rapidly to rising inflation, which has allowed us to protect our margins.
-
Brand leaders share top tips for scaling social intelligence
Synthesio expert shares social intelligence program best practices and mistakes to avoid .
-
Beyond omnichannel to convergent commerce ecosystems
Integrating retail into consumers’ everyday lives
-
Editorial
On 17 March 2020, we entered uncharted territory, as anti-Covid-19 measured were announced. What followed was like something of another age or of a bizarre planet from a science fiction novel that no publisher would have published: pandemic, lockdowns, curfews, social distancing, vaccine passes, pro-vax, anti-vax...
-
Media consumption: The crisis has boosted audiences and gaming
How has the health crisis changed the French people’s relationship with the media?